Biomimetic approaches to modulating the T cell immune response with nano- and micro- particles

Proceedings of the 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society: Engineering the Future of Biomedicine, EMBC 2009

Volumn , Issue , 2009, Pages 1161-1166

  Demento, Stacey ^a   Steenblock, Erin R ^a   Fahmy, Tarek M ^a  

^a Yale University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; BIOMIMETICS; CELLS; CYTOLOGY; IMMUNIZATION; SURFACE TREATMENT; T-CELLS; VACCINES;

ANTIGEN PRESENTATION; BIODEGRADABLE NANOPARTICLE; BIOMIMETIC APPROACHES; CELLULAR THERAPEUTICS; CELLULAR THERAPY; LIPOPOLYSACCHARIDES; MICRON-SIZED PARTICLES; NANO- AND MICRO-PARTICLES;

IMMUNE SYSTEM;

EID: 77951011799     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/IEMBS.2009.5332625     Document Type: Conference Paper

References (18)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
2. Mellman, I. 2005. Antigen processing and presentation by dendritic cells: cell biological mechanisms. Adv Exp Med Biol 560:63-67.
3. Gupta, R. K., and G. R. Siber. 1995. Adjuvants for human vaccines-current status, problems and future prospects. Vaccine 13:1263-1276.
4. Lindblad, E. B. 2004. Aluminium adjuvants-in retrospect and prospect. Vaccine 22:3658-3668.
5. Gupta, R. K., E. H. Relyveld, E. B. Lindblad, B. Bizzini, S. Ben- Efraim, and C. K. Gupta. 1993. Adjuvants-a balance between toxicity and adjuvanticity. Vaccine 11:293-306.
6. Singh, M., and I. Srivastava. 2003. Advances in vaccine adjuvants for infectious diseases. Curr HIV Res 1:309-320.
7. O'Hagan, D. T., and N. M. Valiante. 2003. Recent advances in the discovery and delivery of vaccine adjuvants. Nat Rev Drug Discov 2:727-735.
8. Singh, M., and D. O'Hagan. 1999. Advances in vaccine adjuvants. Nat Biotechnol 17:1075-1081.
9. Oelke, M., M. V. Maus, D. Didiano, C. H. June, A. Mackensen, and J. P. Schneck. 2003. Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigenpresenting cells. Nat Med 9:619-624.
10. Oelke, M., C. Krueger, R. L. Giuntoli, 2nd, and J. P. Schneck. 2005. Artificial antigen-presenting cells: artificial solutions for real diseases. Trends Mol Med 11:412-420.
11. Kim, J. V., J. B. Latouche, I. Riviere, and M. Sadelain. 2004. The ABCs of artificial antigen presentation. Nat Biotechnol 22:403-410.
12. Reis e Sousa, C. 2004. Toll-like receptors and dendritic cells: for whom the bug tolls. Semin Immunol 16:27-34.
13. Bellou, A., B. Schaub, L. Ting, and P. W. Finn. 2003. Toll receptors modulate allergic responses: interaction with dendritic cells, T cells and mast cells. Curr Opin Allergy Clin Immunol 3:487-494.
14. Fahmy, T. M., E. Steenblock, and I. Mellman. 2008. A comprehensive platform for T cell stimulation based on biodegradable artificial antigen-presenting cell microparticles. Molecular Therapy 16.
15. Demento, S., S. Eisenbarth, H. Foellmer, C. Platt, M. H. Caplan, W. M. Saltzman, I. Mellman, M. Ledizet, E. Fikrig, R. A. Flavell, and T. M. Fahmy. 2009. Inflammasome-activating biodegradable nanoparticulates as vaccine delivery systems. Vaccine In Press.
16. Ledizet, M., K. Kar, H. G. Foellmer, T. Wang, S. L. Bushmich, J. F. Anderson, E. Fikrig, and R. A. Koski. 2005. A recombinant envelope protein vaccine against West Nile virus. Vaccine 23:3915-3924.
17. Jain, R. A. 2000. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 21:2475-2490.
18. Fahmy, T. M., R. M. Samstein, C. C. Harness, and W. Mark Saltzman. 2005. Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting. Biomaterials 26:5727-5736.